An open-label phase I trial of a live attenuated H2N2 influenza virus vaccine in healthy adults.
Talaat KR, Karron RA, Liang PH, McMahon BA, Luke CJ, Thumar B, Chen GL, Min JY, Lamirande EW, Jin H, Coelingh KL, Kemble GW, Subbarao K.
Talaat KR, et al. Among authors: mcmahon ba.
Influenza Other Respir Viruses. 2013 Jan;7(1):66-73. doi: 10.1111/j.1750-2659.2012.00350.x. Epub 2012 Mar 14.
Influenza Other Respir Viruses. 2013.
PMID: 22417012
Free PMC article.
Clinical Trial.